Ori­gi­nal-Re­se­arch: Ce­n­it AG (by GBC AG): BUY

Re­se­arch | 6 Au­gust 2025 12:00

Ori­gi­nal-Re­se­arch: Ce­n­it AG – by GBC AG

06.08.2025 / 12:00 CET/CEST
Dis­se­mi­na­ti­on of a Re­se­arch, trans­mit­ted by EQS News – a ser­vice of EQS Group.
The is­suer is so­le­ly re­spon­si­ble for the con­tent of this re­se­arch. The re­sult of this re­se­arch does not con­sti­tu­te in­vest­ment ad­vice or an in­vi­ta­ti­on to con­clude cer­tain stock ex­ch­an­ge tran­sac­tions.


Clas­si­fi­ca­ti­on of GBC AG to Ce­n­it AG

Com­pa­ny Name: Ce­n­it AG
ISIN: DE0005407100
Re­ason for the re­se­arch: Re­se­arch Com­ment
Re­com­men­da­ti­on: BUY
Tar­get pri­ce: 16.00 EUR
Tar­get pri­ce on sight of: 31.12.2026
Last ra­ting ch­an­ge:
Ana­lyst: Cos­min Fil­ker, Mar­cel Gold­mann

Ana­ly­sis Prime weighs on re­ve­nue and ear­nings; fo­re­cast and pri­ce tar­get lo­we­red, BUY ra­ting con­firm­ed

Alt­hough CENIT AG in­creased its re­ve­nue by 4.4% to €103.71 mil­li­on in the first half of 2025 (pre­vious year: €93.36 mil­li­on), this per­for­mance fell si­gni­fi­cant­ly short of our ex­pec­ta­ti­ons and tho­se of CEN­I­T’s ma­nage­ment. The in­crease in re­ve­nue was ex­clu­si­ve­ly at­tri­bu­ta­ble to the re­ve­nues of the US com­pa­ny Ana­ly­sis Prime, which was ac­qui­red in July 2024 and was in­cluded in the fi­gu­res for the first half of the year for the first time. Ac­cor­ding to our cal­cu­la­ti­ons, the­se re­ve­nues are li­kely to have amoun­ted to slight­ly more than €6 mil­li­on. Ac­cor­ding to for­mer esti­ma­tes, Ana­ly­sis Prime should ge­ne­ra­te sa­les of around €25 mil­li­on in the 2025 fi­nan­cial year. Ho­we­ver, in view of the sa­les achie­ved in the first half of the year, this fo­re­cast is cle­ar­ly too op­ti­mi­stic. Res­truc­tu­ring me­a­su­res are curr­ent­ly un­der­way at this sub­si­dia­ry, par­ti­cu­lar­ly at ma­nage­ment le­vel. At the same time, the con­ti­nuing dif­fi­cult mar­ket en­vi­ron­ment in Eu­ro­pe is ma­king its­elf felt. The Ger­man au­to­mo­ti­ve in­dus­try, in par­ti­cu­lar, which is an im­portant cus­to­mer sec­tor for the com­pa­ny, is af­fec­ted by a de­cli­ne in busi­ness vo­lu­me, with the re­sult that CENIT AG had to ac­cept an or­ga­nic de­cli­ne in re­ve­nue of around 2%.

De­spi­te the in­crease in re­ve­nue, EBIT de­te­rio­ra­ted to €-3.69 mil­li­on (pre­vious year: €2.01 mil­li­on). In the first half of 2025, spe­cial ex­pen­ses of around €3.8 mil­li­on were in­cur­red in con­nec­tion with the im­ple­men­ta­ti­on of the ‘Pro­ject Per­for­mance’ res­truc­tu­ring pro­gram­me. This pro­gram­me aims to re­du­ce the num­ber of em­ployees by around 50. Alt­hough this has re­sul­ted in cost im­pro­ve­ments, si­gni­fi­cant po­si­ti­ve ef­fects are not ex­pec­ted to be­co­me ap­pa­rent un­til the co­ming fi­nan­cial year. In ad­di­ti­on to the spe­cial ex­pen­ses, Ana­ly­sis Prime re­por­ted a ne­ga­ti­ve EBIT of €1.6 mil­li­on in the first half of 2025, which also had a ne­ga­ti­ve im­pact on the Group’s re­sults.

De­spi­te the ne­ga­ti­ve ope­ra­ting re­sult, ope­ra­ting cash flow was once again cle­ar­ly po­si­ti­ve at €9.99 mil­li­on (pre­vious year: €11.15 mil­li­on). Ad­van­ce pay­ments re­cei­ved con­tri­bu­ted si­gni­fi­cant­ly to this, mea­ning that CENIT AG re­mains in a very com­for­ta­ble po­si­ti­on with cash and cash equi­va­lents of €20.59 mil­li­on as of 30 June 2025.

Due to the be­low-ex­pec­ta­ti­ons per­for­mance of Ana­ly­sis Prime and the con­ti­nuing dif­fi­cult mar­ket si­tua­ti­on, CEN­I­T’s ma­nage­ment has si­gni­fi­cant­ly ad­jus­ted its fo­re­cast. Re­ve­nue of at least €205 mil­li­on and EBIT of at least €-1.5 mil­li­on are now ex­pec­ted. Pre­vious­ly, re­ve­nue of €229 mil­li­on to €234 mil­li­on and EBIT of €6.8 mil­li­on to €7.3 mil­li­on had been ex­pec­ted. The main re­ason for this re­duc­tion in the fo­re­cast is Ana­ly­sis Prime, for which sa­les of around €15 mil­li­on are curr­ent­ly plan­ned, a si­gni­fi­cant ad­jus­t­ment com­pared to the pre­vious ex­pec­ta­ti­on of around €25 mil­li­on. In ad­di­ti­on, the weak mar­ket si­tua­ti­on in Eu­ro­pe is caus­ing cus­to­mers to re­main cau­tious.

We are gui­ded by the new fo­re­cast and ex­pect re­ve­nue of €208.95 mil­li­on and EBIT of €-0.28 mil­li­on. For the se­cond half of 2025, this me­ans a re­turn to po­si­ti­ve EBIT. This is pri­ma­ri­ly a re­sult of the vir­tu­al eli­mi­na­ti­on of spe­cial ex­pen­ses, which amoun­ted to €3.8 mil­li­on in the first half of the year. The eli­mi­na­ti­on of the­se ex­pen­ses in the co­ming fi­nan­cial year and the re­sul­ting po­si­ti­ve ef­fects of ap­pro­xi­m­ate­ly €5 mil­li­on should have a si­gni­fi­cant po­si­ti­ve im­pact on EBIT in the co­ming fi­nan­cial year. Due to the now lower re­ve­nue base, we have re­du­ced our re­ve­nue fo­re­casts for 2026 to €221.35 mil­li­on (pre­vious­ly: €242.22 mil­li­on). Ho­we­ver, we ex­pect a no­ti­ceable im­pro­ve­ment in EBIT to €11.21 mil­li­on (pre­vious­ly: €13.40 mil­li­on). The same ap­pli­es to the 2027 fi­nan­cial year.

Ba­sed on the ad­jus­ted DCF va­lua­ti­on mo­del, we have de­ter­mi­ned a new tar­get pri­ce of €16.00 (pre­vious­ly: €19.00). The re­duc­tion in the tar­get pri­ce is a con­se­quence of our lower fo­re­casts. We are main­tai­ning our ‘BUY’ ra­ting.

You can down­load the re­se­arch here: 20250806_CENIT_Comment_engl

Cont­act for ques­ti­ons:
++++++++++++++++
Dis­clo­sure of po­ten­ti­al con­flicts of in­te­rest pur­su­ant to Sec­tion 85 WpHG and Art. 20 MAR The com­pa­ny ana­ly­sed abo­ve has the fol­lo­wing po­ten­ti­al con­flict of in­te­rest: (5a,6a,7,11); A ca­ta­lo­gue of po­ten­ti­al con­flicts of in­te­rest can be found at:

https://​www​.gbc​-ag​.de/​d​e​/​O​f​f​e​n​l​e​g​u​n​g​.​htm
+++++++++++++++
Date and time of com­ple­ti­on of the stu­dy: 06/08/25 (10:19 am)
Date and time of the first dis­se­mi­na­ti­on of the stu­dy: 06/08/25 (12:00 pm)

Cont­act

Stu­dies

GBC AG
Hal­der­stra­ße 27
86150 Augs­burg

Te­le­fon: +49 821 241133–0
E‑mail: office(@)gbc-ag.de

Fol­low us!